LGT Group Foundation’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
LGT Group Foundation's BMY Position: Q1 2026 in Review
LGT Group Foundation held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 19,824 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #189.
LGT Group Foundation first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $43.4M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- LGT Group Foundation held 19,824 shares of Bristol-Myers Squibb worth $1.2M as of Q1 2026.
- LGT Group Foundation left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.01% of LGT Group Foundation's portfolio in Q1 2026, its #189 holding.
- LGT Group Foundation first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- LGT Group Foundation's Bristol-Myers Squibb position peaked at $43.4M in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on LGT Group Foundation's 13F filing for Q1 2026, filed 28 Apr 2026.